Most Viewed Posts Clear Filters Neuroprotective effect of a new photobiomodulation technique against Aβ25-35 peptide-induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer’s disease suggested 2 February 2018 The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis 6 June 2018 Designing a unique treatment protocol by assessing efficient photonic and magnetic emission parameters on an Alzheimer’s disease animal model 25 January 2019 Clear Filters Alzheimer1 April 2026 Alzheimer’s disease: REGEnLIFE accelerates its Light4Life clinical trial with the opening of a new trial site at Lyon University Hospital, Hôpital des Charpennes Alzheimer Past Events20 March 2026 MedInTechs 2026 – Parc Floral de Paris | 9 & 10 March Alzheimer Concussions16 March 2026 IN THE SPOTLIGHT – REGEnLIFE: At the crossroads of medicine and physics – Pharmaceutiques Magazine No. 335 / March 2026 Alzheimer16 March 2026 Slowing down neurodegeneration with light Alzheimer16 March 2026 REGEnLIFE, the French NeuroTech DeepTech company shortlisted for the 2025 Prix Galien USA
